TGFB1 and Alzheimer disease: In mice, LNP-R/Aβ treatment was confirmed to induce Aβ-specific Treg cells in AD, as high levels of Treg cell markers (Foxp3) and anti-inflammatory cytokines (TGF-β and IL-10) were detected, significantly reducing the number of Aβ plaques.